|Bid||0.0000 x N/A|
|Ask||0.0000 x N/A|
|Day's range||0.0000 - 0.0000|
|Beta (5Y monthly)||N/A|
|PE ratio (TTM)||N/A|
|Earnings date||08 Aug 2023 - 14 Aug 2023|
|Forward dividend & yield||N/A (N/A)|
|1y target est||N/A|
With the business potentially at an important milestone, we thought we'd take a closer look at Zynerba Pharmaceuticals...
We can readily understand why investors are attracted to unprofitable companies. For example, although...
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...